文献速递甲状腺疾病

高龄老人甲状腺过氧化物酶抗体升高与甲状腺功能、生存、功能状态及抑郁症状的关联:Leiden 85-plus研究

Associations of Elevated Antithyroperoxidase Antibodies with Thyroid Function, Survival, Functioning, and Depressive Symptoms in the Oldest Old: The Leiden 85-plus Study.
PubMed 文献 · Thyroid · 2019-01-01

基于Leiden 85-plus人群队列488名85岁及以上老人,13.1%基线TPOAb≥35 IU/mL,其横断面与较高TSH相关;纵向TPOAb升高与较低死亡风险独立相关(HR 0.72,95%CI 0.53-0.99),但与甲状腺功能变化、躯体功能、ADL残疾、认知功能及抑郁症状均无关联。

要点

  • 高龄老人TPOAb升高(≥35 IU/mL)横断面与较高TSH及甲减患病率相关。
  • TPOAb升高与较低死亡风险独立相关(HR 0.72,95%CI 0.53-0.99)。
  • TPOAb升高未与甲状腺功能变化、功能状态或抑郁症状相关。

核心结论

  • 社区高龄老人中,TPOAb升高横断面与较高TSH相关,纵向与生存获益相关但未与甲状腺功能变化、功能状态或抑郁症状相关。
  • 对高龄甲状腺功能异常者,TPOAb检测的附加临床价值有限。

研究设计与样本

  • 基于荷兰Leiden 85-plus人群队列研究,纳入85岁及以上居民,488名参与者有基线血清TPOAb数据(占总队列82%)。
  • TPOAb≥35 IU/mL定义为升高;甲状腺功能在85、87、88岁评估,生存、躯体功能、ADL残疾、认知功能及抑郁症状从85岁随访至90岁。

主要发现

  • 基线时85岁参与者中64人(13.1%)TPOAb升高,且更常为女性、TSH更高、显性或亚临床甲减患病率更高。
  • 纵向分析中,TPOAb升高独立与较低死亡风险相关(HR 0.72,95%CI 0.53-0.99)。
  • TPOAb升高与甲状腺功能变化、躯体功能、ADL残疾、认知功能及抑郁症状均无关联。

关键数值与推荐

  • TPOAb升高定义为血清水平≥35 IU/mL。
  • TPOAb升高与较低死亡风险的独立关联:HR 0.72(95%CI 0.53-0.99)。

临床怎么用

  • 对社区高龄老人,TPOAb升高提示横断面TSH较高,但不应据此预期甲状腺功能进行性变化或功能状态下降。
  • TPOAb升高与生存获益相关,但TPOAb检测在高龄甲状腺功能异常者中的附加临床价值有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Elevated levels of antithyroperoxidase antibodies (TPOAbs) have been associated with progression of subclinical thyroid dysfunction, extrathyroidal diseases, and decrease in functional status. However, TPOAb as determinant of future thyroid dysfunction and other clinical outcomes has not been studied well for adults aged 85 years and over. This study aimed to assess associations of TPOAb levels with thyroid function, survival, physical function, disability in activities of daily living (ADL), cognitive function, and depressive symptoms in the oldest old. Methods: Data from a population-based cohort study (Leiden 85-plus Study) of residents of Leiden, the Netherlands, aged 85 and older were used. Baseline serum TPOAb levels were available for 488 participants (82% of the total cohort). We considered levels ≥35 IU/mL as elevated. Thyroid function (thyrotropin [TSH] and free thyroxine) was assessed at age 85 (baseline), 87, and 88 years. Survival, physical function, disability in ADL, cognitive function, and depressive symptoms were assessed from age 85 through 90 years. Results: At baseline, 64 of the 85-year old participants (13.1%) had elevated TPOAb levels. They were more often female, had higher TSH levels, and a higher prevalence of overt or subclinical hypothyroidism than participants with normal TPOAb levels. Over time, elevated TPOAb levels were independently associated with a lower mortality risk (hazard ratio 0.72, [95% confidence interval 0.53-0.99]), but were not associated with changes in thyroid function, nor with physical function, disability in ADL, cognitive function, or depressive symptoms. Conclusions: In community-dwelling oldest old, elevated TPOAb levels are cross-sectionally associated with higher TSH levels. Over time, elevated TPOAb levels are associated with a survival benefit but are not associated with changes in thyroid function, functional status, or depressive symptoms in old age. The added clinical value of TPOAb tests in oldest old persons with thyroid dysfunction is limited.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Du Puy RS, Poortvliet RKE, Snel M, et al. Associations of Elevated Antithyroperoxidase Antibodies with Thyroid Function, Survival, Functioning, and Depressive Symptoms in the Oldest Old: The Leiden 85-plus Study. Thyroid. 2019. PMID: 31382845. doi:10.1089/thy.2019.0129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。